Jun 7 |
Investors in Amicus Therapeutics (NASDAQ:FOLD) from a year ago are still down 19%, even after 3.9% gain this past week
|
Jun 5 |
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
Jun 4 |
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
|
May 24 |
Do Options Traders Know Something About Amicus (FOLD) Stock We Don't?
|
May 20 |
Amicus Therapeutics: Too Cheap At Under $10 A Share
|
May 10 |
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
|
May 10 |
Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
|
May 10 |
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
|
May 10 |
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
May 9 |
Amicus Therapeutics, Inc. (FOLD) Q1 2024 Earnings Call Transcript
|